and Nobutaka Hanagata

Dr. and Nobutaka Hanagata


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2014 in Nanoscale
Verified
Journal Article
Closed access
PDF file
XYXi Yang
Xi Yang
JLJie Li
Jie Li
TLTao Liang
Tao Liang
CMChunyan Ma
Chunyan Ma
YZYingying Zhang
Yingying Zhang
MXMingsheng Xu
Mingsheng Xu
Graphene-like two-dimensional materials (2DMats) show application potential in optoelectronics and biomedicine due to their unique properties. However, environmental and biological influences of these 2DMats remain to be unveiled. Here we reported the antibacterial activity of two-dimensional (2D) chemically exfoliated MoS2 (ce-MoS2) sheets. We found that the antibacterial activity of ce-MoS2 sheets was much more potent than that of the raw MoS2 powders used for the synthesis of ce-MoS2 sheets possibly due to the 2D planar structure (high specific surface area) and higher conductivity of the ce-MoS2. We investigated the antibacterial mechanisms of the ce-MoS2 sheets and proposed their antibacterial pathways. We found that the ce-MoS2 sheets could produce reactive oxygen species (ROS), different from a previous report on graphene-based materials. Particularly, the oxidation capacity of the ce-MoS2 sheets toward glutathione oxidation showed a time and concentration dependent trend, which is fully consistent with the antibacterial behaviour of the ce-MoS2 sheets. The results suggest that antimicrobial behaviors were attributable to both membrane and oxidation stress. The antibacterial pathways include MoS2–bacteria contact induced membrane stress, superoxide anion (O2˙−) induced ROS production by the ce-MoS2, and the ensuing superoxide anion-independent oxidation. Our study thus indicates that the tailoring of the dimension of nanomaterials and their electronic properties would manipulate antibacterial activity.

1 April 2012 in International Journal of Nanomedicine
Verified
Journal Article
Open access
AHand Nobutaka Hanagata
and Nobutaka Hanagata
Peer reviewed article authored by (Hanagata N). Read article or submit your manuscript for publishing.

15 August 2013 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
Shanmugavel ChinnathambiShanmugavel Chinnathambi
Shanmugavel Chinnathambi
SCSong Chen
Song Chen
SGSingaravelu Ganesan
Singaravelu Ganesan
AHand Nobutaka Hanagata
and Nobutaka Hanagata

18 November 2011 in ACS Nano
Verified
Journal Article
Closed access
AHand Nobutaka Hanagata
and Nobutaka Hanagata
FZFei Zhuang
Fei Zhuang
SCSarah Connolly
Sarah Connolly
JLJie Li
Jie Li
NONobuhiro Ogawa
Nobuhiro Ogawa
MXMingsheng Xu
Mingsheng Xu

1 January 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AHand Nobutaka Hanagata
and Nobutaka Hanagata
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and cellular immunity and are being developed as vaccine adjuvants to prevent or treat cancers, infectious diseases, and allergies. Free CpG ODNs have been used in many clinical trials implemented to verify their effects. However, recent research has reported that self-assembled CpG ODNs, protein/peptide–CpG ODN conjugates, and nanomaterial–CpG ODN complexes demonstrate higher adjuvant effects than free CpG ODNs, owing to their improved uptake efficiency into cells expressing TLR9. Moreover, protein/peptide–CpG ODN conjugates and nanomaterial–CpG ODN complexes are able to deliver CpG ODNs and antigens (or allergens) to the same types of cells, which enables a higher degree of prophylaxis or therapeutic effect. In this review, the author describes recent trends in the research and development of CpG ODN nanomedicines containing self-assembled CpG ODNs, protein/peptide–CpG ODN conjugates, and nanomaterial–CpG ODN complexes, focusing mainly on the results of preclinical and clinical studies.

30 December 2016 in Langmuir
Verified
Journal Article
Closed access
XYXianxian Yao
Xianxian Yao
ZTZhengfang Tian
Zhengfang Tian
JLJiaxing Liu
Jiaxing Liu
YZYufang Zhu
Yufang Zhu
AHand Nobutaka Hanagata
and Nobutaka Hanagata